Quince Therapeutics, Inc. (QNCX)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch QNCX
See up to 3 months of QNCX. The 7-day demo opens the 1M and 3M ranges and puts QNCX on your watchlist.
Start 7-day demoLatest QNCX insider trades
- Luca BenattiOpen-market sale$174K
David LamondGrant or award2,700 sh- Christopher J. SennerGrant or award
About Quince Therapeutics, Inc. (QNCX)
The SEC lists Quince Therapeutics, Inc. under CIK 0001662774, in biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
QNCX Form 4 activity by transaction type, last 90 days
No Form 4 activity for QNCX in the last 90 days.
QNCX insider transactions (Form 4)
2012 Form 4 filings on record, the earliest from Jun 4, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David Lamond | Grant or award | Director Stock Option (Right to Buy) | 2,700 | $0.00 | - | |
| Christopher J. Senner | Grant or award | Director Stock Option (Right to Buy) | 2,700 | $0.00 | - | |
| Brigette Roberts - Officer | Grant or award | Employee Stock Option (Right to Buy) | 69,350 | - footnote F5 | - | |
| Brigette Roberts - Officer | Grant or award | Employee Stock Option (Right to Buy) | 362,092 | - footnote F6 | - | |
| Brigette Roberts - Officer | Grant or award | Employee Stock Option (Right to Buy) | 133,615 | - footnote F7 | - | |
| Brigette Roberts - Officer | Grant or award | Employee Stock Option (Right to Buy) | 2,070,107 | - footnote F8 | - | |
| Brigette Roberts - Officer | Grant or award | Employee Stock Option (Right to Buy) | 6,837,319 | - footnote F9 | - | |
| Brigette Roberts - Officer | Grant or award | Employee Stock Option (Right to Buy) | 6,837,319 | - footnote F9 | - | |
| Brigette Roberts - Officer | Grant or award | Employee Stock Option (Right to Buy) | 34,675 | - footnote F1 | - | |
| Brigette Roberts - Officer | Grant or award | Employee Stock Option (Right to Buy) | 228,855 | - footnote F3 | - | |
| Brigette Roberts - Officer | Grant or award | Employee Stock Option (Right to Buy) | 124,830 | - footnote F4 | - | |
| ||||||
| Dirk Thye - Officer | Grant or award | Employee Stock Option (Right to Buy) | 1,000,000 | $0.00 | - | |
| Charles S. Ryan - Officer | Grant or award | Employee Stock Option (Right to Buy) | 200,000 | $0.00 | - | |
| Brendan Hannah - Officer | Grant or award | Employee Stock Option (Right to Buy) | 365,000 | $0.00 | - | |
| Christopher J. Senner | Grant or award | Director Stock Option (Right to Buy) | 21,810 | $0.00 | - | |
| Margaret McLoughlin | Grant or award | Director Stock Option (Right to Buy) | 19,547 | $0.00 | - | |
| David Lamond | Grant or award | Director Stock Option (Right to Buy) | 29,423 | $0.00 | - | |
| June Bray | Grant or award | Director Stock Option (Right to Buy) | 18,724 | $0.00 | - | |
| Luca Benatti | Open-market sale | Common Stock | 50,000 | $3.47 footnote F1 | $174K | |
| ||||||
 Una S. Ryan | Grant or award | Director Stock Option (Right to Buy) | 27,000 | $0.00 | - | |
Item 5.02, 5.03, 7.01, 8.01, 9.01
Item 5.02, 5.03, 5.07, 9.01
Item 5.02
Item 2.01, 5.02, 9.01
QNCX insider trading FAQ
What is the latest insider trade for QNCX?
Quince Therapeutics, Inc. (QNCX) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-15. The full record for QNCX runs to 12 Form 4 filings, the earliest from 2025-06-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying QNCX stock?
No insider purchases of QNCX were filed in the last 90 days.
How many insiders are selling QNCX stock?
No insider sales of QNCX were filed in the last 90 days. 1 sale is on record for this company.
Where can I see QNCX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects QNCX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - David Lamond view on EDGAR
- - Christopher J. Senner view on EDGAR
- - Brigette Roberts view on EDGAR
- - Dirk Thye view on EDGAR
- - Charles S. Ryan view on EDGAR
- - Brendan Hannah view on EDGAR
- - Christopher J. Senner view on EDGAR
- - Margaret McLoughlin view on EDGAR
- - David Lamond view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where QNCX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow QNCX with a 7-day demo
- QNCX on your watchlist
- Every QNCX Form 4 filing on record
- Up to 3 months of QNCX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
